CXCR4 S338X clonality is an important determinant of ibrutinib outcomes in patients with Waldenström macroglobulinemia
Titel:
CXCR4 S338X clonality is an important determinant of ibrutinib outcomes in patients with Waldenström macroglobulinemia
Auteur:
Gustine, Joshua N. Xu, Lian Tsakmaklis, Nicholas Demos, Maria G. Kofides, Amanda Chen, Jiaji G. Liu, Xia Munshi, Manit Guerrera, Maria Luisa Chan, Gloria G. Patterson, Christopher J. Keezer, Andrew Meid, Kirsten Dubeau, Toni Yang, Guang Hunter, Zachary R. Treon, Steven P. Castillo, Jorge J.